CYP2C9 and VKORC1 genotypes in Puerto Ricans: A case for admixture-matching in clinical pharmacogenetic studies.
about
Effect of genetic variants, especially CYP2C9 and VKORC1, on the pharmacology of warfarinPharmacogenetic association study of warfarin safety endpoints in Puerto RicansPharmacogenetics of drug-metabolizing enzymes in US Hispanics.A Novel Admixture-Based Pharmacogenetic Approach to Refine Warfarin Dosing in Caribbean Hispanics.The Emerging Role of Admixture in the Pharmacogenetics of Puerto Rican Hispanics.Development of a pharmacogenetic-guided warfarin dosing algorithm for Puerto Rican patientsInclusion and exclusion in nutrigenetics clinical research: ethical and scientific challenges.Pharmacogenetic research activity in Central America and the Caribbean: a systematic review.Why admixture matters in genetically-guided therapy: missed targets in the COAG and EU-PACT trials.Proposal of pharmacogenetics-based warfarin dosing algorithm in Korean patients.Are research papers reporting results from nutrigenetics clinical research a potential source of biohype?
P2860
Q28276514-C5AEAD83-738B-4609-A5FE-78C2F74A0BD4Q34337948-0315C832-9443-4CDF-9643-87FB9B4DC3C5Q35661209-A2E2B1A1-F5CA-433D-B201-9871C5318554Q35888757-25C14619-215B-489B-8C9F-810BF67F4BF7Q36447492-D05EC692-2CBC-4036-B7DB-99AF16AB0222Q36511894-7F102605-1909-49C8-806D-4061F09297D9Q37981029-02CFB56D-DEF3-4C82-93C8-412BDD1AB12DQ38955593-CDB3D137-DBB7-4671-A91D-8C0F8ED1D3A6Q42602646-7FA0A272-602F-40AA-953C-11C63B1BD704Q42750392-C0C9FE18-1EE0-44E1-AD8D-3A947E91248BQ48382416-6CF75EDC-50B7-4784-9082-277E8F38343D
P2860
CYP2C9 and VKORC1 genotypes in Puerto Ricans: A case for admixture-matching in clinical pharmacogenetic studies.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
CYP2C9 and VKORC1 genotypes in ...... nical pharmacogenetic studies.
@ast
CYP2C9 and VKORC1 genotypes in ...... nical pharmacogenetic studies.
@en
type
label
CYP2C9 and VKORC1 genotypes in ...... nical pharmacogenetic studies.
@ast
CYP2C9 and VKORC1 genotypes in ...... nical pharmacogenetic studies.
@en
prefLabel
CYP2C9 and VKORC1 genotypes in ...... nical pharmacogenetic studies.
@ast
CYP2C9 and VKORC1 genotypes in ...... nical pharmacogenetic studies.
@en
P2093
P2860
P1433
P1476
CYP2C9 and VKORC1 genotypes in ...... nical pharmacogenetic studies.
@en
P2093
Andreas Windemuth
Carmen L Cadilla
David Villagra
Gualberto Ruaño
Irelys A Cruz
Jessica Y Renta
Jorge Duconge
Kali Bogaard
Krystyna Gorowski
Mohan Kocherla
P2860
P304
P356
10.1016/J.CCA.2010.05.021
P577
2010-05-19T00:00:00Z